ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)

Abstract Background Neoadjuvant therapy is increasingly the standard of care in the management of locally advanced adenocarcinoma of the oesophagus and junction (AEG). In randomised controlled trials (RCTs), the MAGIC regimen of pre- and postoperative chemotherapy, and the CROSS regimen of preoperat...

Popoln opis

Bibliografske podrobnosti

Principais autores:	JV Reynolds, SR Preston, B O’Neill, L Baeksgaard, SM Griffin, C Mariette, S Cuffe, M Cunningham, T Crosby, I Parker, K Hofland, G Hanna, LB Svendsen, CL Donohoe, C Muldoon, D O’Toole, C Johnson, N Ravi, G Jones, AK Corkhill, M Illsley, J Mellor, K Lee, M Dib, V Marchesin, M Cunnane, K Scott, P Lawner, S Warren, S O’Reilly, G O’Dowd, G Leonard, B Hennessy, R Mc Dermott
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2017-06-01
Serija:	BMC Cancer
Teme:	Oesophageal Oesophagogastric junction Adenocarcinoma Neoadjuvant chemoradiation therapy Neoadjuvant chemotherapy
Online dostop:	http://link.springer.com/article/10.1186/s12885-017-3386-2
Oznake:	Označite Brez oznak, prvi označite!